As of 2026-09-25, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (22.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.21 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1983.0%.
The range of the Relative Valuation is (20.65) - (24.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 30.1x | 27.6x |
| Forward P/E multiples | 25.2x - 30.8x | 28.0x |
| Fair Price | (20.65) - (24.67) | (22.78) |
| Upside | -1806.9% - -2138.8% | -1983.0% |
| Date | P/E |
| 2026-09-24 | -1.44 |
| 2026-09-23 | -1.53 |
| 2026-09-22 | -1.57 |
| 2026-09-21 | -1.51 |
| 2026-09-18 | -1.51 |
| 2026-09-17 | -1.48 |
| 2026-09-16 | -1.40 |
| 2026-09-15 | -1.42 |
| 2026-09-14 | -1.44 |
| 2026-09-11 | -1.53 |
| 2026-09-10 | -1.56 |
| 2026-09-09 | -1.61 |
| 2026-09-08 | -1.73 |
| 2026-09-04 | -1.74 |
| 2026-09-03 | -1.66 |
| 2026-09-02 | -1.66 |
| 2026-09-01 | -1.62 |
| 2026-08-31 | -1.55 |
| 2026-08-28 | -1.57 |
| 2026-08-27 | -1.54 |
| 2026-08-26 | -1.59 |
| 2026-08-25 | -1.57 |
| 2026-08-24 | -1.53 |
| 2026-08-21 | -1.44 |
| 2026-08-20 | -1.48 |
| 2026-08-19 | -1.59 |
| 2026-08-18 | -1.46 |
| 2026-08-17 | -1.40 |
| 2026-08-14 | -1.33 |
| 2026-08-13 | -1.10 |
| 2026-08-12 | -0.94 |
| 2026-08-11 | -0.93 |
| 2026-08-10 | -0.90 |
| 2026-08-07 | -0.82 |
| 2026-08-06 | -0.82 |
| 2026-08-05 | -0.83 |
| 2026-08-04 | -0.81 |
| 2026-08-03 | -0.85 |
| 2026-07-31 | -0.83 |
| 2026-07-30 | -0.80 |
| 2026-07-29 | -1.27 |
| 2026-07-28 | -1.26 |
| 2026-07-27 | -1.18 |
| 2026-07-24 | -1.18 |
| 2026-07-23 | -1.24 |
| 2026-07-22 | -1.29 |
| 2026-07-21 | -1.34 |
| 2026-07-20 | -1.33 |
| 2026-07-17 | -1.37 |
| 2026-07-16 | -1.37 |